Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

MicroRNA regulating stanniocalcin-1 is a metastasis and dissemination promoting factor in glioblastoma.

Sakata J, Sasayama T, Tanaka K, Nagashima H, Nakada M, Tanaka H, Hashimoto N, Kagawa N, Kinoshita M, Nakamizo S, Maeyama M, Nishihara M, Hosoda K, Kohmura E.

J Neurooncol. 2019 Apr;142(2):241-251. doi: 10.1007/s11060-019-03113-2. Epub 2019 Jan 30.

PMID:
30701354
2.

Stanniocalcin-1 augments stem-like traits of glioblastoma cells through binding and activating NOTCH1.

Li Y, He ZC, Zhang XN, Liu Q, Chen C, Zhu Z, Chen Q, Shi Y, Yao XH, Cui YH, Zhang X, Wang Y, Kung HF, Ping YF, Bian XW.

Cancer Lett. 2018 Mar 1;416:66-74. doi: 10.1016/j.canlet.2017.11.033. Epub 2017 Nov 28.

PMID:
29196129
3.

Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.

Liu J, Jiang J, Hui X, Wang W, Fang D, Ding L.

Cell Physiol Biochem. 2018;48(5):2074-2083. doi: 10.1159/000492545. Epub 2018 Aug 10.

4.

Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.

Ma X, Gu L, Li H, Gao Y, Li X, Shen D, Gong H, Li S, Niu S, Zhang Y, Fan Y, Huang Q, Lyu X, Zhang X.

J Transl Med. 2015 Feb 12;13:56. doi: 10.1186/s12967-015-0421-4.

5.

Expression of stanniocalcin-1 and stanniocalcin-2 in laryngeal squamous cell carcinoma and correlations with clinical and pathological parameters.

Zhou H, Li YY, Zhang WQ, Lin D, Zhang WM, Dong WD.

PLoS One. 2014 Apr 17;9(4):e95466. doi: 10.1371/journal.pone.0095466. eCollection 2014.

6.

miR-144-3p serves as a tumor suppressor by targeting FZD7 and predicts the prognosis of human glioblastoma.

Cheng ZX, Song YX, Wang ZY, Wang Y, Dong Y.

Eur Rev Med Pharmacol Sci. 2017 Sep;21(18):4079-4086.

7.

Upregulation of stanniocalcin-1 inhibits the development of osteoarthritis by inhibiting survival and inflammation of fibroblast-like synovial cells.

Wu Y, Li Z, Jia W, Li M, Tang M.

J Cell Biochem. 2019 Jun;120(6):9768-9780. doi: 10.1002/jcb.28257. Epub 2018 Dec 23.

PMID:
30582210
8.

Secretory Stanniocalcin 1 promotes metastasis of hepatocellular carcinoma through activation of JNK signaling pathway.

Chan KK, Leung CO, Wong CC, Ho DW, Chok KS, Lai CL, Ng IO, Lo RC.

Cancer Lett. 2017 Sep 10;403:330-338. doi: 10.1016/j.canlet.2017.06.034. Epub 2017 Jul 6.

PMID:
28688970
9.

miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM.

Yue S, Wang L, Zhang H, Min Y, Lou Y, Sun H, Jiang Y, Zhang W, Liang A, Guo Y, Chen P, Lv G, Wang L, Zong Q, Li Y.

Tumour Biol. 2015 Sep;36(9):6741-9. doi: 10.1007/s13277-015-3372-8. Epub 2015 Apr 3.

PMID:
25833697
10.

MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44.

Yu G, Yao W, Xiao W, Li H, Xu H, Lang B.

J Exp Clin Cancer Res. 2014 Dec 31;33:779. doi: 10.1186/s13046-014-0115-4.

11.

Decreased levels of miR-224 and the passenger strand of miR-221 increase MBD2, suppressing maspin and promoting colorectal tumor growth and metastasis in mice.

Yuan K, Xie K, Fox J, Zeng H, Gao H, Huang C, Wu M.

Gastroenterology. 2013 Oct;145(4):853-64.e9. doi: 10.1053/j.gastro.2013.06.008. Epub 2013 Jun 13.

12.

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients.

Qiu S, Lin S, Hu D, Feng Y, Tan Y, Peng Y.

J Transl Med. 2013 Jan 9;11:10. doi: 10.1186/1479-5876-11-10.

13.

HMGB3 promotes the proliferation and metastasis of glioblastoma and is negatively regulated by miR-200b-3p and miR-200c-3p.

Liu J, Wang L, Li X.

Cell Biochem Funct. 2018 Oct;36(7):357-365. doi: 10.1002/cbf.3355. Epub 2018 Sep 19.

PMID:
30232806
14.

Modulation of MicroRNAs 34a and 21 Affects Viability, Senescence, and Invasion in Glioblastoma Multiforme.

Yin Y, Ornell KJ, Beliveau A, Jain A.

J Biomed Nanotechnol. 2016 Sep;12(9):1782-97.

PMID:
29345889
15.

MicroRNA-873 (miRNA-873) inhibits glioblastoma tumorigenesis and metastasis by suppressing the expression of IGF2BP1.

Wang RJ, Li JW, Bao BH, Wu HC, Du ZH, Su JL, Zhang MH, Liang HQ.

J Biol Chem. 2015 Apr 3;290(14):8938-48. doi: 10.1074/jbc.M114.624700. Epub 2015 Feb 10.

16.

Dual Functional MicroRNA-186-5p Targets both FGF2 and RelA to Suppress Tumorigenesis of Glioblastoma Multiforme.

Wang F, Jiang H, Wang S, Chen B.

Cell Mol Neurobiol. 2017 Nov;37(8):1433-1442. doi: 10.1007/s10571-017-0474-4. Epub 2017 Feb 17.

PMID:
28213656
17.

miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme.

Yin D, Ogawa S, Kawamata N, Leiter A, Ham M, Li D, Doan NB, Said JW, Black KL, Phillip Koeffler H.

Oncogene. 2013 Feb 28;32(9):1155-63. doi: 10.1038/onc.2012.132. Epub 2012 May 14.

18.

miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2.

Chung HJ, Choi YE, Kim ES, Han YH, Park MJ, Bae IH.

Oncotarget. 2015 Jul 30;6(21):18429-44.

19.

Current Progress on Understanding MicroRNAs in Glioblastoma Multiforme.

Karsy M, Arslan E, Moy F.

Genes Cancer. 2012 Jan;3(1):3-15. doi: 10.1177/1947601912448068.

20.

miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2.

Pang H, Zheng Y, Zhao Y, Xiu X, Wang J.

Biochem Biophys Res Commun. 2015 Dec 25;468(4):739-45. doi: 10.1016/j.bbrc.2015.11.025. Epub 2015 Nov 7.

PMID:
26556542

Supplemental Content

Support Center